These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16422002)

  • 1. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
    Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
    Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
    Kojima S; Yamada T; Tamai M
    Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy.
    Aksünger A; Or M; Okur H; Hasanreisoğlu B; Akbatur H
    Ophthalmologica; 1997; 211(4):223-5. PubMed ID: 9216011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Feb; 96(1):e27-e37. PubMed ID: 28391660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy.
    Mao C; Yan H
    Indian J Ophthalmol; 2014 Jun; 62(6):699-701. PubMed ID: 25005199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
    Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
    Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
    Ozaki H; Hayashi H; Oshima K
    Ophthalmic Res; 1996; 28(6):356-60. PubMed ID: 9032794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.
    El-Ghrably IA; Dua HS; Orr GM; Fischer D; Tighe PJ
    Br J Ophthalmol; 2001 Apr; 85(4):461-70. PubMed ID: 11264138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
    El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
    Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
    Sydorova M; Lee MS
    Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.